EXICURE, INC. Fair Value Adjustment of Warrants
EXICURE, INC. (XCUR) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2023-03-27
- EXICURE, INC. fair value adjustment of warrants for the quarter ending 2022-12-31 was $0.00.
- EXICURE, INC. fair value adjustment of warrants for the quarter ending 2022-09-30 was $0.00.
- EXICURE, INC. fair value adjustment of warrants for the quarter ending 2021-12-31 was $0.00.
- EXICURE, INC. fair value adjustment of warrants for the quarter ending 2021-09-30 was $0.00.
- EXICURE, INC. fair value adjustment of warrants for fiscal 2022 was $0.00.
- EXICURE, INC. fair value adjustment of warrants for fiscal 2021 was -$15.00K.
- EXICURE, INC. fair value adjustment of warrants for fiscal 2020 was -$399.00K.
- EXICURE, INC. fair value adjustment of warrants for fiscal 2019 was -$383.00K, a 239.78% decline from fiscal 2018.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 3 month as first filed | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | $0.00 10-K · filed 2023-03-27 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $0.00 derived: sum of 2 quarters · filed 2023-03-27 | -$13.00K derived: sum of 3 quarters · filed 2023-03-27 | -$15.00K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$13.00K derived: sum of 2 quarters · filed 2022-11-14 | -$15.00K 10-Q · filed 2022-11-14 | -$71.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$15.00K 10-Q · filed 2022-08-15 | -$71.00K derived: sum of 3 quarters · filed 2022-08-15 | -$257.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$2.00K 10-Q · filed 2021-05-12 | -$58.00K derived: sum of 2 quarters · filed 2021-05-12 | -$244.00K derived: sum of 3 quarters · filed 2021-05-12 | -$55.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-12-31 | -$56.00K 10-K · filed 2021-03-11 | -$242.00K derived: sum of 2 quarters · filed 2021-03-11 | -$53.00K derived: sum of 3 quarters · filed 2021-03-11 | -$399.00K 10-K · filed 2022-03-25 | |
| 2020-09-30 | -$186.00K 10-K · filed 2021-03-11 | $3.00K derived: sum of 2 quarters · filed 2021-03-11 | -$343.00K 10-Q · filed 2021-11-19 | -$367.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-06-30 | $189.00K 10-K · filed 2021-03-11 | -$157.00K 10-Q · filed 2021-08-12 | -$181.00K derived: sum of 3 quarters · filed 2021-05-12 | -$284.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2020-03-31 | -$346.00K 10-Q · filed 2021-05-12 | -$370.00K derived: sum of 2 quarters · filed 2021-05-12 | -$473.00K derived: sum of 3 quarters · filed 2021-05-12 | -$360.00K derived: sum of 4 quarters · filed 2021-05-12 | |
| 2019-12-31 | -$24.00K 10-K · filed 2021-03-11 | $24.00K 10-K · filed 2020-03-10 | -$127.00K derived: sum of 2 quarters · filed 2021-03-11 | -$14.00K derived: sum of 3 quarters · filed 2021-03-11 | -$383.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | -$103.00K 10-K · filed 2021-03-11 | $103.00K 10-K · filed 2020-03-10 | $10.00K derived: sum of 2 quarters · filed 2021-03-11 | -$360.00K 10-Q · filed 2020-11-12 | -$174.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $113.00K 10-K · filed 2021-03-11 | -$113.00K 10-K · filed 2020-03-10 | -$256.00K 10-Q · filed 2020-08-12 | -$71.00K derived: sum of 3 quarters · filed 2021-03-11 | $510.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$370.00K 10-K · filed 2021-03-11 | -$369.00K 10-Q · filed 2019-05-08 | -$184.00K derived: sum of 2 quarters · filed 2021-03-11 | $397.00K derived: sum of 3 quarters · filed 2021-03-11 | -$518.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $186.00K 10-K · filed 2020-03-10 | $767.00K derived: sum of 2 quarters · filed 2020-03-10 | -$148.00K derived: sum of 3 quarters · filed 2020-03-10 | $274.00K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $581.00K 10-K · filed 2020-03-10 | -$334.00K derived: sum of 2 quarters · filed 2020-03-10 | $461.00K 10-Q · filed 2019-11-07 | -$475.00K derived: sum of 4 quarters · filed 2020-03-10 | |
| 2018-06-30 | -$915.00K 10-K · filed 2020-03-10 | $1.04M 10-Q · filed 2019-08-08 | -$1.06M derived: sum of 3 quarters · filed 2020-03-10 | -$1.26M derived: sum of 4 quarters · filed 2020-03-10 | |
| 2018-03-31 | -$128.00K 10-K · filed 2020-03-10 | $128.00K 10-Q · filed 2018-05-15 | -$141.00K derived: sum of 2 quarters · filed 2020-03-10 | -$345.00K derived: sum of 3 quarters · filed 2020-03-10 | -$304.00K derived: sum of 4 quarters · filed 2020-03-10 |
| 2017-12-31 | -$13.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | -$217.00K derived: sum of 2 quarters · filed 2019-09-23 | -$176.00K derived: sum of 3 quarters · filed 2019-09-23 | -$214.00K 10-K/A · filed 2019-09-23 | |
| 2017-09-30 | -$204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$163.00K derived: sum of 2 quarters · filed 2018-11-06 | -$201.00K 10-Q · filed 2018-11-06 | -$201.00K derived: sum of 4 quarters · filed 2018-11-06 | |
| 2017-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $3.00K 10-Q · filed 2018-08-06 | $3.00K derived: sum of 3 quarters · filed 2018-08-06 | ||
| 2017-03-31 | -$38.00K 10-Q · filed 2018-05-15 | -$38.00K derived: sum of 2 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $67.00K 10-K · filed 2018-03-09 | |||
| 2016-09-30 | $67.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |